Sahabi, Laila .

HRN: 19-18-78  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2022
CEFTRIAXONE 1G (VIAL)
06/04/2022
06/10/2022
İVT
2g
Od
Uti
Waiting Final Action 
06/05/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/05/2022
06/12/2022
IVT
500mg
Q8hrs
Rule Out Intestinal Obstruction
Waiting Final Action 
06/05/2022
CIPROFLOXACIN 500MG (TAB)
06/05/2022
06/12/2022
PO
1 Tablet
Q12
Acute Pyelonephritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: